CORD-19:500c5ea0961b573ba5355d364ca94c00a0a26e4a / 1694-1879 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T14","span":{"begin":0,"end":185},"obj":"Sentence"},{"id":"TextSentencer_T14","span":{"begin":0,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Silencing the expression of CAV1, FKBP52 with siRNAs or the 30 inhibition of CyA by cyclosporine A resulted in significant decrease in NS1 secretion without 31 affecting virion release."}

{"project":"CORD-PICO","denotations":[{"id":"p1_all3","span":{"begin":84,"end":96},"obj":"Intervention"},{"id":"p1_all4","span":{"begin":135,"end":148},"obj":"Outcome"},{"id":"p2_i0","span":{"begin":84,"end":96},"obj":"Pharmacological"},{"id":"p2_o12","span":{"begin":135,"end":148},"obj":"Physical"}],"text":"Silencing the expression of CAV1, FKBP52 with siRNAs or the 30 inhibition of CyA by cyclosporine A resulted in significant decrease in NS1 secretion without 31 affecting virion release."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T13","span":{"begin":135,"end":138},"obj":"Disease"},{"id":"T22809","span":{"begin":135,"end":138},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0008104"},{"id":"A71969","pred":"mondo_id","subj":"T22809","obj":"http://purl.obolibrary.org/obo/MONDO_0008104"}],"text":"Silencing the expression of CAV1, FKBP52 with siRNAs or the 30 inhibition of CyA by cyclosporine A resulted in significant decrease in NS1 secretion without 31 affecting virion release."}